Response to the letter from Horowitz et al. to the Editor relating to the publication 'Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes' by Dahl et al.

Diabetes Obes Metab

Novo Nordisk A/S, Søborg, Denmark.

Published: October 2021

Download full-text PDF	Source
http://dx.doi.org/10.1111/dom.14485	DOI Listing

Publication Analysis

response letter

letter horowitz

horowitz editor

editor relating

relating publication

publication 'oral

'oral semaglutide

semaglutide improves

improves postprandial

postprandial glucose

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!